Literature DB >> 28375916

Neuropathic Pain.

Lindsay A Zilliox.   

Abstract

PURPOSE OF REVIEW: Neuropathic pain is a frequently encountered condition that is often resistant to treatment and is associated with poor patient satisfaction of their treatment. Several medications have been shown to be effective in treating neuropathic pain associated with diabetic neuropathy and postherpetic neuralgia, and these medications are often used to treat neuropathic pain associated with other conditions as well. This article summarizes the diagnosis and assessment of patients with neuropathic pain as well as available pharmacologic and interventional treatment options. RECENT
FINDINGS: Evidence-based recommendations for the treatment of neuropathic pain have been published, and first-line medications include antidepressants, anticonvulsants, topical agents, as well as opioid analgesics. Interventional options include anesthetic and steroid injections, nerve blocks, and spinal cord stimulation. Essential to the treatment algorithm of neuropathic pain is the assessment and treatment of psychosocial comorbidities and the utilization of a multidisciplinary team approach, including cognitive-behavioral and rehabilitative therapies. Questions remain about the comparative effectiveness of various medications and combination therapies. Increasing interest also exists in the optimization and personalization of pharmacotherapy based upon the underlying mechanism(s) of neuropathic pain according to the quality of the patient's symptoms.
SUMMARY: The management of chronic neuropathic pain is challenging and is best achieved with the use of a multidisciplinary team. Pain is a subjective experience, and it is important to validate a patient's pain, address psychosocial comorbidities, and set realistic treatment goals. Evidence-based guidelines are available to guide treatment, but frequently, high-quality evidence-based recommendations are lacking.

Entities:  

Mesh:

Year:  2017        PMID: 28375916     DOI: 10.1212/CON.0000000000000462

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  37 in total

Review 1.  Regulatory mechanisms and therapeutic potential of microglial inhibitors in neuropathic pain and morphine tolerance.

Authors:  Er-Rong Du; Rong-Ping Fan; Li-Lou Rong; Zhen Xie; Chang-Shui Xu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

Review 2.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

3.  CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.

Authors:  Maciej Gonek; Virginia D McLane; David L Stevens; Kumiko Lippold; Hamid I Akbarali; Pamela E Knapp; William L Dewey; Kurt F Hauser; Jason J Paris
Journal:  Brain Behav Immun       Date:  2017-11-13       Impact factor: 7.217

Review 4.  Neuropathic pain in sickle cell disease: measurement and management.

Authors:  Alexander Glaros; Amanda M Brandow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

5.  Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine.

Authors:  Mihály Balogh; Jelena M Janjic; Andrew J Shepherd
Journal:  Antioxid Redox Signal       Date:  2022-01       Impact factor: 8.401

6.  Downregulation of lncRNA FIRRE relieved the neuropathic pain of female mice by suppressing HMGB1 expression.

Authors:  Yuanyuan Wen; Xiaochong Fan; Huilian Bu; Letian Ma; Cunlong Kong; Chen Huang; Yuming Xu
Journal:  Mol Cell Biochem       Date:  2020-11-05       Impact factor: 3.396

Review 7.  Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.

Authors:  Hannah A Blair
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

8.  Fe3O4@Polydopamine-Labeled MSCs Targeting the Spinal Cord to Treat Neuropathic Pain Under the Guidance of a Magnetic Field.

Authors:  Meichen Liu; Weijia Yu; Fuqiang Zhang; Te Liu; Kai Li; Meng Lin; Ying Wang; Guoqing Zhao; Jinlan Jiang
Journal:  Int J Nanomedicine       Date:  2021-05-11

9.  Pharmacokinetic Modeling of the Impact of P-glycoprotein on Ondansetron Disposition in the Central Nervous System.

Authors:  Manting Chiang; Hyun-Moon Back; Jong Bong Lee; Sarah Oh; Tiffany Guo; Simone Girgis; Celine Park; Simon Haroutounian; Leonid Kagan
Journal:  Pharm Res       Date:  2020-09-28       Impact factor: 4.200

Review 10.  Focused Ultrasound (FUS) for Chronic Pain Management: Approved and Potential Applications.

Authors:  Lazzaro di Biase; Emma Falato; Maria Letizia Caminiti; Pasquale Maria Pecoraro; Flavia Narducci; Vincenzo Di Lazzaro
Journal:  Neurol Res Int       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.